Expressive Writing for Postpartum PTSD
(CARES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a psychological approach to prevent post-traumatic stress disorder (PTSD) after childbirth. Participants will engage in Expressive Writing about Childbirth, writing about their childbirth experience, or in Neutral Writing, writing about a neutral event, for three days to see if this improves their mental health and bond with their baby. Women who gave birth at Massachusetts General Hospital and experienced a stressful delivery might be a good fit. As an unphased trial, this study offers a unique opportunity to explore innovative methods for enhancing mental health after childbirth.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this psychological intervention is safe for postpartum individuals?
Research has shown that expressive writing is generally safe and well-tolerated by participants. Studies have found that writing about personal experiences can help reduce symptoms of PTSD (post-traumatic stress disorder), even in complex cases. Reports of harmful side effects from expressive writing are rare. Most people find it manageable and helpful. Overall, expressive writing has a strong safety record, making it a promising option for those interested in trials to improve mental health after childbirth.12345
Why are researchers excited about this trial?
Researchers are excited about expressive writing for postpartum PTSD because it offers a novel, non-pharmacological approach to managing this condition. Unlike traditional treatments like therapy and medication, this method empowers new mothers to process their childbirth experiences through structured writing exercises. This technique is promising because it could be easily accessible, low-cost, and reduce stigma associated with seeking mental health support.
What evidence suggests that expressive writing might be an effective treatment for postpartum PTSD?
Research has shown that expressive writing can greatly reduce symptoms of post-traumatic stress disorder (PTSD). In this trial, participants will divide into two groups: one will engage in Expressive Writing about Childbirth, while the other will participate in Neutral Writing about daily events. One study found that women who practiced expressive writing experienced less postpartum depression and stress than those who received standard care or wrote about neutral topics. This type of writing helps individuals process their emotions and experiences, which can lower stress. Studies on trauma-focused therapies also support their effectiveness in helping new mothers heal emotionally. Overall, expressive writing appears promising in reducing emotional distress after childbirth.36789
Are You a Good Fit for This Trial?
This trial is for women who recently gave birth at Massachusetts General Hospital and are at risk of developing postpartum PTSD, as indicated by a specific distress score. Participants must understand English and be between the ages of 18-50 without severe mental health conditions, substance abuse issues, or recent psychological treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in expressive writing about their childbirth experience or a neutral event for three consecutive days, 15 minutes each day.
Post-Intervention Assessment
Participants complete a short survey about their birth experience and mental health.
Follow-up
Participants undergo mental health and physiological assessments, and a brief play session with their infant.
What Are the Treatments Tested in This Trial?
Interventions
- Expressive Writing about Childbirth
- Neutral Writing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor